PepGen Insider Trades
NASDAQ: PEPGHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 7 · $59.31K
- Shares bought / sold
- 0 / 10.47K
- Net activity
- Net selling $59,312
PepGen insider activity
Over the last 12 months, PepGen insiders reported 13 transactions on SEC Form 4: 0 open-market purchases and 7 sales. Insiders bought $0 and sold $59,312 worth of stock, for net insider selling of $59,312. The largest seller was McArthur James G, with $32,876 in reported sales.
The most recent filing shows Kasraian Kasra (Chief Technical Officer) selling 1,233 shares at $1.41 on May 21, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put PEPG's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
PEPG insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 21, 2026 | Kasraian KasraChief Technical Officer | Sale | 1,233 | $1.74K | Form 4 |
| Mar 4, 2026 | STRECK PAULEVP, Head of R&D | Sale | 47 | $295.54 | Form 4 |
| Mar 4, 2026 | STRECK PAULEVP, Head of R&D | Sale | 1,832 | $11.41K | Form 4 |
| Mar 4, 2026 | McArthur James GPresident and CEO | Sale | 131 | $828.58 | Form 4 |
| Mar 4, 2026 | McArthur James GPresident and CEO | Sale | 5,144 | $32.05K | Form 4 |
| Mar 4, 2026 | Donnelly NoelChief Financial Officer | Sale | 52 | $328.90 | Form 4 |
| Mar 4, 2026 | Donnelly NoelChief Financial Officer | Sale | 2,032 | $12.66K | Form 4 |
| Mar 1, 2026 | Donnelly NoelChief Financial Officer | Award | 76,793 | — | Form 4 |
| Mar 1, 2026 | STRECK PAULEVP, Head of R&D | Award | 50,300 | — | Form 4 |
| Mar 1, 2026 | Vittiglio JosephChief Business & Legal Officer | Award | 30,717 | — | Form 4 |
| Mar 1, 2026 | McArthur James GPresident and CEO | Award | 187,688 | — | Form 4 |
| Mar 1, 2026 | Kasraian KasraChief Technical Officer | Award | 34,557 | — | Form 4 |
| Dec 8, 2025 | Vittiglio JosephChief Business & Legal Officer | Award | 35,000 | — | Form 4 |
| Sep 30, 2025 | Oxford Science Enterprises plcFormer 10% Owner | Buy | 200,000 | $640.00K | Form 4 |
| Sep 26, 2025 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund II, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Buy | 9,375,000 | $30.00M | Form 4 |
| May 30, 2025 | STRECK PAULEVP, Head of R&D | Buy | 8,375 | $10.39K | Form 4 |
| May 20, 2025 | Kasraian KasraChief Technical Officer | Award | 16,750 | — | Form 4 |
| Apr 17, 2025 | McArthur James GPresident and CEO | Buy | 10,000 | $13.55K | Form 4 |
| Apr 8, 2025 | McArthur James GPresident and CEO | Buy | 41,500 | $47.73K | Form 4 |
| Mar 3, 2025 | STRECK PAULEVP, Head of R&D | Award | 19,430 | — | Form 4 |
| Mar 3, 2025 | McArthur James GPresident and CEO | Award | 60,719 | — | Form 4 |
| Mar 3, 2025 | Donnelly NoelChief Financial Officer | Award | 23,283 | — | Form 4 |
| Mar 3, 2025 | DeLena Mary BethGeneral Counsel | Award | 13,400 | — | Form 4 |
| Feb 26, 2025 | DeLena Mary BethGeneral Counsel | Sale | 1,432 | $2.41K | Form 4 |
| Feb 24, 2025 | DeLena Mary BethGeneral Counsel | Award | 3,000 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4